Sequana Medical NV (EBR:SEQUA)

Sequana Medical NV Statistics

Total Valuation

EBR:SEQUA has a market cap or net worth of EUR 43.61 million. The enterprise value is 77.70 million.

Market Cap	43.61M
Enterprise Value	77.70M

Important Dates

The next estimated earnings date is Monday, December 15, 2025.

Earnings Date	Dec 15, 2025
Ex-Dividend Date	n/a

Share Statistics

EBR:SEQUA has 60.40 million shares outstanding. The number of shares has increased by 54.42% in one year.

Current Share Class	60.40M
Shares Outstanding	60.40M
Shares Change (YoY)	+54.42%
Shares Change (QoQ)	+27.40%
Owned by Insiders (%)	11.67%
Owned by Institutions (%)	13.20%
Float	29.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-1.11
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.50
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.39

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.34
Interest Coverage	-1.65

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-88.40%
Return on Invested Capital (ROIC)	-448.47%
Return on Capital Employed (ROCE)	47.72%
Revenue Per Employee	n/a
Profits Per Employee	-1.08M
Employee Count	48
Asset Turnover	n/a
Inventory Turnover	0.00

Taxes

In the past 12 months, EBR:SEQUA has paid 260,904 in taxes.

Income Tax	260,904
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.77% in the last 52 weeks. The beta is -0.09, so EBR:SEQUA's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-25.77%
50-Day Moving Average	0.90
200-Day Moving Average	1.23
Relative Strength Index (RSI)	32.40
Average Volume (20 Days)	324,633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-355
Operating Income	-17.94M
Pretax Income	-51.59M
Net Income	-51.85M
EBITDA	-17.20M
EBIT	-17.94M
Earnings Per Share (EPS)	-1.11

Balance Sheet

The company has 7.31 million in cash and 41.40 million in debt, giving a net cash position of -34.09 million or -0.56 per share.

Cash & Cash Equivalents	7.31M
Total Debt	41.40M
Net Cash	-34.09M
Net Cash Per Share	-0.56
Equity (Book Value)	-39.17M
Book Value Per Share	-0.68
Working Capital	-41.58M

Cash Flow

In the last 12 months, operating cash flow was -17.63 million and capital expenditures -66,219, giving a free cash flow of -17.69 million.

Operating Cash Flow	-17.63M
Capital Expenditures	-66,219
Free Cash Flow	-17.69M
FCF Per Share	-0.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EBR:SEQUA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.42%
Shareholder Yield	-54.42%
Earnings Yield	-118.89%
FCF Yield	-40.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EBR:SEQUA has an Altman Z-Score of -32.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.69
Piotroski F-Score	2